Presentation is loading. Please wait.

Presentation is loading. Please wait.

Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol  Henry Milgrom, MDa, David P. Skoner,

Published byYandi Hartanto Modified over 6 years ago

Similar presentations

Presentation on theme: "Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol  Henry Milgrom, MDa, David P. Skoner,"— Presentation transcript:

1 Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol  Henry Milgrom, MDa, David P. Skoner, MDb, George Bensch, MDc, Kenneth T. Kim, MDd, Raymond Claus, MSe, Rudolf A. Baumgartner, MDe  Journal of Allergy and Clinical Immunology  Volume 108, Issue 6, Pages (December 2001) DOI: /mai Copyright © 2001 Mosby, Inc. Terms and Conditions

2 Fig. 1 A, Mean change in ventricular HR 30 minutes after dose (least squares [LS] mean ± SEM). Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2001 Mosby, Inc. Terms and Conditions

3 Fig. 1 B, Mean change in potassium 60 minutes after dose (LS mean ± SEM). C, Mean change in glucose 60 minutes after dose (LS mean ± SEM). Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2001 Mosby, Inc. Terms and Conditions

4 Fig. 2 Distribution of patient response (mean change in ventricular HR 30 minutes after dose). Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2001 Mosby, Inc. Terms and Conditions

Download ppt "Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol  Henry Milgrom, MDa, David P. Skoner,"

Similar presentations

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.
W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 

W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 
Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome  Paul Steinberg, MDa, Bruce E.

Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome  Paul Steinberg, MDa, Bruce E.
Kiwi fruit allergy: A new birch pollen–associated food allergy

Kiwi fruit allergy: A new birch pollen–associated food allergy
F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc 

F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc 
Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction  Robert A. Nathan, MDa, Jonathan A.

Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction  Robert A. Nathan, MDa, Jonathan A.
Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.

Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.
Kiwi fruit allergy: A new birch pollen–associated food allergy

Kiwi fruit allergy: A new birch pollen–associated food allergy
A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children  Mark Boguniewicz, MDa, Virginia C. Fiedler,

A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children  Mark Boguniewicz, MDa, Virginia C. Fiedler,
Richard L. ZuWallack, MD a,b, James P

Richard L. ZuWallack, MD a,b, James P
Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma  Patrick Booms, MSca, David.

Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma  Patrick Booms, MSca, David.
Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors  Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,

Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors  Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,
Practice Notes from the AAAI

Practice Notes from the AAAI
Badrul A. Chowdhury, MD, PhD 

Badrul A. Chowdhury, MD, PhD 
Pathophysiology of severe asthma

Pathophysiology of severe asthma
Multicenter, double-blind, placebo-controlled, multiple-challenge evaluation of reported reactions to monosodium glutamate  Raif S. Geha, MDa, Alexa Beiser,

Multicenter, double-blind, placebo-controlled, multiple-challenge evaluation of reported reactions to monosodium glutamate  Raif S. Geha, MDa, Alexa Beiser,
Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.

Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.
Product characteristics and pharmacokinetics of intranasal ipratropium bromide  Chester C. Wood, MDa, Philip Fireman, MDb, Jay Grossman, MDc, Margaret.

Product characteristics and pharmacokinetics of intranasal ipratropium bromide  Chester C. Wood, MDa, Philip Fireman, MDb, Jay Grossman, MDc, Margaret.
Harold B. Kaiser, MDa, Steven R. Findlay, MD†, John W

Harold B. Kaiser, MDa, Steven R. Findlay, MD†, John W

Similar presentations

Ads by Google